Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Methylphenidate and cognitive therapy in children with attention deficit disorder: a double-blind trial.

Brown RT, Wynne ME, Borden KA, Clingerman SR, Geniesse R, Spunt AL.

J Dev Behav Pediatr. 1986 Jun;7(3):163-74.

PMID:
3522630
2.

Methylphenidate and cognitive therapy with ADD children: a methodological reconsideration.

Brown RT, Borden KA, Wynne ME, Schleser R, Clingerman SR.

J Abnorm Child Psychol. 1986 Dec;14(4):481-97.

PMID:
3782621
3.

Attention deficit disorder with hyperactivity: differential effects of methylphenidate on impulsivity.

Rapport MD, DuPaul GJ, Stoner G, Birmingham BK, Masse G.

Pediatrics. 1985 Dec;76(6):938-43.

PMID:
4069863
6.

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J.

Pediatrics. 1999 Apr;103(4):e43.

PMID:
10103335
7.
8.

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD.

Pediatrics. 2001 Jun;107(6):E105.

PMID:
11389303
9.

Sequential evaluation of behavioral treatments and methylphenidate dosage for children with attention deficit hyperactivity disorder.

Gulley V, Northup J, Hupp S, Spera S, LeVelle J, Ridgway A.

J Appl Behav Anal. 2003 Fall;36(3):375-8.

10.

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.

Pediatrics. 2005 Jun;115(6):e749-57. Review.

PMID:
15930203
11.

An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.

Nikles CJ, Mitchell GK, Del Mar CB, Clavarino A, McNairn N.

Pediatrics. 2006 Jun;117(6):2040-6.

PMID:
16740846
12.
13.

Dosage effects and individual responsivity to methylphenidate in attention deficit disorder.

Douglas VI, Barr RG, Amin K, O'Neill ME, Britton BG.

J Child Psychol Psychiatry. 1988 Jul;29(4):453-75.

PMID:
3063718
14.

Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.

Akhondzadeh S, Tavakolian R, Davari-Ashtiani R, Arabgol F, Amini H.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):841-5.

PMID:
12921918
15.
16.

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ; COMACS Study Group.

Pediatrics. 2004 Mar;113(3 Pt 1):e206-16.

PMID:
14993578
19.

Double-blind methylphenidate trials: practical, useful, and highly endorsed by families.

Kent MA, Camfield CS, Camfield PR.

Arch Pediatr Adolesc Med. 1999 Dec;153(12):1292-6.

PMID:
10591309
20.

Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit-hyperactivity disorder in the classroom.

Pelham WE Jr, Carlson C, Sams SE, Vallano G, Dixon MJ, Hoza B.

J Consult Clin Psychol. 1993 Jun;61(3):506-15.

PMID:
8326053
Items per page

Supplemental Content

Write to the Help Desk